Download PDF
Fortschr Neurol Psychiatr 2012; 80(5): 288-299
DOI: 10.1055/s-0031-1299431
Fort- und Weiterbildung

© Georg Thieme Verlag KG Stuttgart · New York

Persistierendes Foramen ovale und Schlaganfall

Patent Foramen Ovale and StrokeM.-L. Mono1 , K. Nedeltchev2
  • 1Universitätsklinik für Neurologie, Inselspital Bern, Schweiz
  • 2Abteilung Neurologie, Stadtspital Triemli, Zürich, Schweiz
Further Information

Publication History

Publication Date:
07 May 2012 (online)

    Permissions and Reprints

Lernziele

Dieser Fortbildungsartikel gibt einen Überblick über die aktuelle Datenlage zum Thema persistierendes Foramen ovale (PFO) und Schlaganfall. Die Schwerpunkte liegen auf dem Zusammenhang zwischen PFO und erstmaligem zerebrovaskulären Ereignis, dem Schlaganfall-Rezidivrisiko und schließlich der Sekundärprophylaxe.

Literatur

  • 1 Cohnheim J. Thrombose und Embolie. Vorlesung über allgemeine Pathologie. Berlin: Hirschwald; 1877: 134
    Google Scholar
  • 2 Lechat P, Mas J L, Lascault G et al. Prevalence of patent foramen ovale in patients with stroke.  N Engl J Med. 1988;  318 1148-1152
    Google Scholar
  • 3 Webster M W, Chancellor A M, Smith H J et al. Patent foramen ovale in young stroke patients.  Lancet. 1988;  2 11-12
    Google Scholar
  • 4 Karamlou T, Diggs B S, Ungerleider R M et al. The rush to atrial septal defect closure: Is the introduction of percutaneous closure driving utilization?.  Ann Thorac Surg. 2008;  86 1584-1590 ; discussion 1590 – 1581
    Google Scholar
  • 5 Hagen P T, Scholz D G, Edwards W D. Incidence and size of patent foramen ovale during the first 10 decades of life: An autopsy study of 965 normal hearts.  Mayo Clin Proc. 1984;  59 17-20
    Google Scholar
  • 6 Di Tullio M R, Sacco R L, Sciacca R R et al. Patent foramen ovale and the risk of ischemic stroke in a multiethnic population.  J Am Coll Cardiol. 2007;  49 797-802
    Google Scholar
  • 7 Meissner I, Khandheria B K, Heit J A et al. Patent foramen ovale: Innocent or guilty? Evidence from a prospective population-based study.  J Am Coll Cardiol. 2006;  47 440-445
    Google Scholar
  • 8 Hansen A, Kuecherer H. Caught in the act: Entrapped embolus through a patent foramen ovale.  Eur J Echocardiogr. 2008;  9 692-693
    Google Scholar
  • 9 Ozdemir A O, Tamayo A, Munoz C et al. Cryptogenic stroke and patent foramen ovale: Clinical clues to paradoxical embolism.  J Neurol Sci. 2008;  275 121-127
    Google Scholar
  • 10 Lamy C, Giannesini C, Zuber M et al. Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: The pfo-asa study. Atrial septal aneurysm.  Stroke. 2002;  33 706-711
    Google Scholar
  • 11 Pezzini A, Del Zotto E, Magoni M et al. Inherited thrombophilic disorders in young adults with ischemic stroke and patent foramen ovale.  Stroke. 2003;  34 28-33
    Google Scholar
  • 12 Lethen H, Flachskampf F A, Schneider R et al. Frequency of deep vein thrombosis in patients with patent foramen ovale and ischemic stroke or transient ischemic attack.  Am J Cardiol. 1997;  80 1066-1069
    Google Scholar
  • 13 Gautier J C, Durr A, Koussa S et al. Paradoxal cerebral embolism: Role of patent oval foramen.  Bull Acad Natl Med. 1990;  174 1031-1038 ; discussion 1038 – 1040
    Google Scholar
  • 14 Ranoux D, Cohen A, Cabanes L et al. Patent foramen ovale: Is stroke due to paradoxical embolism?.  Stroke. 1993;  24 31-34
    Google Scholar
  • 15 Stollberger C, Slany J, Schuster I et al. The prevalence of deep venous thrombosis in patients with suspected paradoxical embolism.  Ann Intern Med. 1993;  119 461-465
    Google Scholar
  • 16 Itoh T, Matsumoto M, Handa N et al. Paradoxical embolism as a cause of ischemic stroke of uncertain etiology. A transcranial doppler sonographic study.  Stroke. 1994;  25 771-775
    Google Scholar
  • 17 Hanna J P, Sun J P, Furlan A J et al. Patent foramen ovale and brain infarct. Echocardiographic predictors, recurrence, and prevention.  Stroke. 1994;  25 782-786
    Google Scholar
  • 18 Klotzsch C, Janssen G, Berlit P. Transesophageal echocardiography and contrast-tcd in the detection of a patent foramen ovale: Experiences with 111 patients.  Neurology. 1994;  44 1603-1606
    Google Scholar
  • 19 Cramer S C, Rordorf G, Maki J H et al. Increased pelvic vein thrombi in cryptogenic stroke: Results of the paradoxical emboli from large veins in ischemic stroke (pelvis) study.  Stroke. 2004;  35 46-50
    Google Scholar
  • 20 Sevitt S, Gallagher N. Venous thrombosis and pulmonary embolism. A clinico-pathological study in injured and burned patients.  Br J Surg. 1961;  48 475-489
    Google Scholar
  • 21 Horton S C, Bunch T J. Patent foramen ovale and stroke.  Mayo Clin Proc. 2004;  79 79-88
    Google Scholar
  • 22 Berthet K, Lavergne T, Cohen A et al. Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause.  Stroke. 2000;  31 398-403
    Google Scholar
  • 23 Handke M, Harloff A, Bode C et al. Patent foramen ovale and cryptogenic stroke: A matter of age?.  Semin Thromb Hemost. 2009;  35 505-514
    Google Scholar
  • 24 Schneider B, Zienkiewicz T, Jansen V et al. Diagnosis of patent foramen ovale by transesophageal echocardiography and correlation with autopsy findings.  Am J Cardiol. 1996;  77 1202-1209
    Google Scholar
  • 25 Thanigaraj S, Valika A, Zajarias A et al. Comparison of transthoracic versus transesophageal echocardiography for detection of right-to-left atrial shunting using agitated saline contrast.  Am J Cardiol. 2005;  96 1007-1010
    Google Scholar
  • 26 Serena J, Marti-Fabregas J, Santamarina E et al. Recurrent stroke and massive right-to-left shunt: Results from the prospective spanish multicenter (codicia) study.  Stroke. 2008;  39 3131-3136
    Google Scholar
  • 27 Overell J R, Bone I, Lees K R. Interatrial septal abnormalities and stroke: A meta-analysis of case-control studies.  Neurology. 2000;  55 1172-1179
    Google Scholar
  • 28 Handke M, Harloff A, Olschewski M et al. Patent foramen ovale and cryptogenic stroke in older patients.  N Engl J Med. 2007;  357 2262-2268
    Google Scholar
  • 29 Petty G W, Khandheria B K, Meissner I et al. Population-based study of the relationship between patent foramen ovale and cerebrovascular ischemic events.  Mayo Clin Proc. 2006;  81 602-608
    Google Scholar
  • 30 Poppert H, Morschhaeuser M, Feurer R et al. Lack of association between right-to-left shunt and cerebral ischemia after adjustment for gender and age.  J Negat Results Biomed. 2008;  7 7
    Google Scholar
  • 31 Alsheikh-Ali A A, Thaler D E, Kent D M. Patent foramen ovale in cryptogenic stroke: Incidental or pathogenic?.  Stroke. 2009;  40 2349-2355
    Google Scholar
  • 32 Mas J L, Arquizan C, Lamy C et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both.  N Engl J Med. 2001;  345 1740-1746
    Google Scholar
  • 33 De Castro S, Cartoni D, Fiorelli M et al. Morphological and functional characteristics of patent foramen ovale and their embolic implications.  Stroke. 2000;  31 2407-2413
    Google Scholar
  • 34 Homma S, Sacco R L, Di Tullio M R et al. Effect of medical treatment in stroke patients with patent foramen ovale: Patent foramen ovale in cryptogenic stroke study.  Circulation. 2002;  105 2625-2631
    Google Scholar
  • 35 Almekhlafi M A, Wilton S B, Rabi D M et al. Recurrent cerebral ischemia in medically treated patent foramen ovale: A meta-analysis.  Neurology. 2009;  73 89-97
    Google Scholar
  • 36 Anzola G P, Zavarize P, Morandi E et al. Transcranial doppler and risk of recurrence in patients with stroke and patent foramen ovale.  Eur J Neurol. 2003;  10 129-135
    Google Scholar
  • 37 Schuchlenz H W, Weihs W, Horner S et al. The association between the diameter of a patent foramen ovale and the risk of embolic cerebrovascular events.  Am J Med. 2000;  109 456-462
    Google Scholar
  • 38 Nedeltchev K, Arnold M, Wahl A et al. Outcome of patients with cryptogenic stroke and patent foramen ovale.  J Neurol Neurosurg Psychiatry. 2002;  72 347-350
    Google Scholar
  • 39 Harrer J U, Wessels T, Franke A et al. Stroke recurrence and its prevention in patients with patent foramen ovale.  Can J Neurol Sci. 2006;  33 39-47
    Google Scholar
  • 40 Orgera M A, O’Malley P G, Taylor A J. Secondary prevention of cerebral ischemia in patent foramen ovale: Systematic review and meta-analysis.  South Med J. 2001;  94 699-703
    Google Scholar
  • 41 Kiblawi F M, Sommer R J, Levchuck S G. Transcatheter closure of patent foramen ovale in older adults.  Catheter Cardiovasc Interv. 2006;  68 136-142 ; discussion 143 – 134
    Google Scholar
  • 42 Anzola G P, Morandi E, Casilli F et al. Does transcatheter closure of patent foramen ovale really “Shut the door?” A prospective study with transcranial doppler.  Stroke. 2004;  35 2140-2144
    Google Scholar
  • 43 Spies C, Khandelwal A, Timmermanns I et al. Incidence of atrial fibrillation following transcatheter closure of atrial septal defects in adults.  Am J Cardiol. 2008;  102 902-906
    Google Scholar
  • 44 Krumsdorf U, Ostermayer S, Billinger K et al. Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1000 consecutive patients.  J Am Coll Cardiol. 2004;  43 302-309
    Google Scholar
  • 45 Wahl A, Krumsdorf U, Meier B et al. Transcatheter treatment of atrial septal aneurysm associated with patent foramen ovale for prevention of recurrent paradoxical embolism in high-risk patients.  J Am Coll Cardiol. 2005;  45 377-380
    Google Scholar
  • 46 Wahl A, Meier B. Patent foramen ovale and ventricular septal defect closure.  Heart. 2009;  95 70-82
    Google Scholar
  • 47 Khairy P, O’Donnell C P, Landzberg M J. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: A systematic review.  Ann Intern Med. 2003;  139 753-760
    Google Scholar
  • 48 Schuchlenz H W, Weihs W, Berghold A et al. Secondary prevention after cryptogenic cerebrovascular events in patients with patent foramen ovale.  Int J Cardiol. 2005;  101 77-82
    Google Scholar
  • 49 Windecker S, Wahl A, Nedeltchev K et al. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke.  J Am Coll Cardiol. 2004;  44 750-758
    Google Scholar
  • 50 Furlan A, Mauri L, Adams H et al. Late breaking clinical trial and science abstracts from the american heart association’s scientific session 2010; abstract 21 752: Closure i: A prospective, multicenter, randomized, controlled trial to evaluate the safety and efficacy of the starflex® septal closure system versus best medical therapy in patients with a stroke or transient ischemic attack due to presumed paradoxical embolism through a patent foramen ovale.  Circulation research. 2010;  122 2215
    Google Scholar
  • 51 Mono M L, Geister L, Galimanis A et al. Patent foramen ovale may be causal for the first stroke but unrelated to subsequent ischemic events.  Stroke. 2011;  42 2891-2895
    Google Scholar
  • 52 Mattle H P, Meier B, Nedeltchev K. Prevention of stroke in patients with patent foramen ovale.  Stroke. 2010;  5 92-102
    Google Scholar

Dr. Marie-Luise Mono

Universitätsklinik für Neurologie, Inselspital Bern

Freiburgstr. 4

3010 Bern

Schweiz

Email: marie-luise.mono@insel.ch

      >